Recently Viewed
Clear All$62.00
$-0.78
(-1.24%)
As on 24-Mar-2026 16:00EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$2,933 Mln
Revenue (TTM)
$1,104 Mln
Net Profit (TTM)
$187 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
15.8
P/B Ratio
1.6
Industry P/E
24.44
EV/EBITDA
11.4
Div. Yield
0 %
Debt to Equity
0.6
Book Value
$--
EPS
$3.8
Face value
--
Shares outstanding
47,318,730
CFO
$1,931.72 Mln
EBITDA
$2,958.86 Mln
Net Profit
$1,053.99 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Prestige Consumer Healthcare (PBH)
| 0.5 | -11.0 | -0.5 | -26.4 | 0.6 | 6.7 | 2.2 |
|
BSE Sensex
| -12.5 | -11.1 | -13.4 | -3.7 | 8.5 | 8.2 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Prestige Consumer Healthcare (PBH)
| -21.0 | 27.3 | -2.2 | 3.2 | 73.9 | -13.9 | 31.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Prestige Consumer Healthcare (PBH)
|
62.0 | 2,932.6 | 1,103.8 | 186.5 | 27.9 | 10.1 | 15.8 | 1.6 |
| 11.3 | 3,410.4 | 510.2 | 146.9 | 37.2 | 35.6 | 23.9 | 7.2 | |
| 12.1 | 3,722.1 | 3,018.8 | 72.1 | 12.6 | -80 | 53.8 | 86.1 | |
| 158.8 | 8,027.0 | 638.5 | -183.2 | -27.4 | -252.1 | -- | 92.0 | |
| 68.5 | 13,287.4 | 502.1 | -729.3 | -125.8 | 41.2 | -- | 123.7 | |
| 33.8 | 3,684.8 | 761.4 | 99.7 | 7.3 | 15 | 42.2 | 5.7 | |
| 13.5 | 11,772.8 | 345,831.0 | 56,586.0 | 21.5 | 15.8 | 19.6 | 3.0 | |
| 24.9 | 11,922.1 | 4,715.0 | -232.0 | 0.9 | -3.7 | -- | 1.9 | |
| 7.6 | 7,645.3 | 7,227.1 | 386.1 | 16.6 | 6.9 | 13.8 | 0.9 | |
| 201.7 | 4,084.1 | 268.1 | 124.5 | 60.0 | 13.5 | 33.5 | 4.0 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates... in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. Read more
Chairman, President & CEO
Mr. Ronald M. Lombardi
Senior Vice President of Operations
Mr. Jeffrey Zerillo
Headquarters
Tarrytown, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Prestige Consumer Healthcare Inc (PBH) is $62.00 (NYSE) as of 24-Mar-2026 16:00 EDT. Prestige Consumer Healthcare Inc (PBH) has given a return of 0.55% in the last 3 years.
The P/E ratio of Prestige Consumer Healthcare Inc (PBH) is 15.84 times as on 20-Mar-2026, a 35 discount to its peers’ median range of 24.44 times.
The P/B ratio of Prestige Consumer Healthcare Inc (PBH) is 1.55 times as on 20-Mar-2026, a 73 discount to its peers’ median range of 5.69 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
20.06
|
2.35
|
|
2024
|
17.44
|
2.21
|
|
2023
|
-37.89
|
2.16
|
|
2022
|
13.14
|
1.71
|
|
2021
|
13.52
|
1.64
|
The 52-week high and low of Prestige Consumer Healthcare Inc (PBH) are Rs 89.37 and Rs 57.25 as of 25-Mar-2026.
Prestige Consumer Healthcare Inc (PBH) has a market capitalisation of $ 2,933 Mln as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Prestige Consumer Healthcare Inc (PBH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.